News
ANGO
11.08
+1.65%
0.18
AngioDynamics announces Humana Medicare Advantage policy for NanoKnife
TipRanks · 6h ago
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
Barchart · 11h ago
AngioDynamics Price Target Cut to $18.00/Share From $19.00 by HC Wainwright & Co.
Dow Jones · 1d ago
AngioDynamics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
Benzinga · 1d ago
AngioDynamics price target lowered to $18 from $19 at H.C. Wainwright
TipRanks · 1d ago
Weekly Report: what happened at ANGO last week (1005-1009)?
Weekly Report · 2d ago
AngioDynamics Price Target Maintained With a $20.00/Share by Canaccord Genuity
Dow Jones · 5d ago
AngioDynamics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 5d ago
Analysts Offer Insights on Healthcare Companies: AngioDynamics (ANGO), Neurocrine (NBIX) and DENTSPLY SIRONA (XRAY)
TipRanks · 5d ago
AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript
NASDAQ · 5d ago
AngioDynamics Earnings Call Highlights MedTech-Fueled Momentum
TipRanks · 5d ago
AngioDynamics (ANGO) Stock Price Sinks As Losses Cloud Med Tech Progress
Simply Wall St · 5d ago
Here are the major earnings before the open Thursday
Seeking Alpha · 5d ago
AngioDynamics Stock Is Falling Thursday: What's Going On?
Benzinga · 6d ago
AngioDynamics Shares Slide on Appointment of New CEO
Dow Jones · 6d ago
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
Benzinga · 6d ago
AngioDynamics Down Over 21%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk
Dow Jones · 6d ago
Why AngioDynamics Crashed Today
The Motley Fool · 6d ago
AngioDynamics Q1 2027 Earnings Call: Complete Transcript
Benzinga · 6d ago
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.